The predominant source of circulating fibronectin is the liver [64] and, in animal models, the major source of fibronectin in early stages of FSGS is from the circulation with deposition of glomerular fibronectin occurring later in the disease process [64]. The gene discussed is FN1; the disease is focal segmental glomerulosclerosis.